359
STRUCTURED CONTENT
Atopy, allergy and eczema
Healthcare Service Utilization by 116,816 Patients with Atopic Dermatitis in Israel, G. Shalom, et al.
Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis, L.U. Ivert, et al.
370–374
375–378
Itch, urticaria and neurodermatology
Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind,
Placebo-controlled, Cross-over, Phase-II trial (APREPRU), A. Tsianakas, et al.
Mortality of Haemodialysis Patients With and Without Chronic Itch: A Follow-up Study of the German
Epidemiological Hemodialysis Itch Study (GEHIS), K. Grochulska, et al.
Itch in Psoriasis: A New Look at Well-known Subject, R. Reszke, et al.
Plasma Dynorphin A Concentration Reflects the Degree of Pruritus in Chronic Liver Disease: A Preliminary
Report, C. Sagita Moniaga, et al.
379–385
423–428
429–434
442–443
Psoriasis and autoimmune diseases
Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional
Survey Study, M.E. Otero, et al.
A Cost-utility Analysis of Calcipotriol/betamethasone Dipropionate Aerosol Foam versus Ointment for the
Topical Treatment of Psoriasis Vulgaris in Sweden, A. Duvetorp, et al.
Psoriasis Incidence and Lifetime Prevalence: Suggestion for a Higher Mortality Rate in Older Age-classes
among Psoriatic Patients Compared to the General Population in Italy, E. Pezzolo, et al.
Polymorphisms in Corticotrophin-releasing Hormone-proopiomelanocortin (CRH-POMC) System Genes
are Associated with Plaque Psoriasis, T. Traks, et al.
A Case of Ixekizumab-induced Psoriasiform Eruption, T. Oiwa, et al.
Combining Omalizumab with Another Biotherapy, A-C. Fougerousse, et al.
386–392
393–399
400–403
444–445
446–447
448–449
Immunology, lymphoma and HIV/AIDS
Disfiguring Nodular Cephalic Xanthoma Disseminatum: An Exceptional Variant of a Forgotten Entity,
A. Bonometti, et al.
450–451
Drug development and adverse reactions
Pruritus in Patients Under Targeted Anticancer Therapy: A Multidimensional Analysis Using the 5-D Itch
Scale, S.I. Cho, et al.
435–441
Skin tumours and pigmentation
Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study, L.M. Serna-Higuita, et al.
Characteristics and Trends of Cutaneous Squamous Cell Carcinoma in a Patient Cohort in Finland 2006-
2015, N. Korhonen, et al.
Massive Localized Lymphedema, an Emerging Problem and a Challenging Pseudosarcomatous Condition
Mimicking Liposarcoma, A.G. Florek, et al.
Effect of Topical Rapamycin 1% on Multiple Trichoepitheliomas, I. Dreyfus, et al.
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report, C. Yang, et al.
404–411
412–416
452–453
454–455
456–457
Inherited diseases and malformations
Skin Cancer Associated Genodermatoses: A Literature Review, J. Schierbeck, et al.
A Japanese Case of Galli-Galli Disease due to a Previously Unreported POGLUT1 Mutation, M. Kono, et al.
A Silent COL17A1 Variant Alters Splicing and Causes Junctional Epidermolysis Bullosa, J. Hoffmann, et al.
360–369
458–459
460–461
Microbiology, STI and genital dermatology
High-risk Mucosal Human Papillomavirus Infection in Squamous Cell Carcinoma and Bowen’s Disease of
the Hand, S. Dorfer, et al.
Severe Septic Vasculitis Preceding Thoracic Empyema: Staphylococcus aureus Enterotoxin Deposition in
Vessel Walls as a Possible Pathomechanism, Y. Yamaguchi, et al.
An Asymptomatic Verrucous Nodule on the Scrotum: A Quiz, Y-T. Qian, et al.
462–463
464–465
466–467
Psychodermatology and quality of life
Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms:
Results of a Multivariate Study of 300 Spanish Individuals with Psoriasis, M.J. Tribó, et al.
417–422
Acta Derm Venereol 2019; 99: 359